Clinical Genetics · Baltimore, MD
NPI
1538118542
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
601 N Caroline St
Baltimore, MD, 21287
Phone (410) 955-3071
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,708
40 services
Medicare patients, 2024
19
Average age 41
Drug cost, 2024
$3.1M
158 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ada Hamosh was code 99215 (office e&m - established), 16 times for 14 patients. In total Ada Hamosh billed 40 services in 10 codes, and Medicare paid $2,708.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 16 | 14 | $79.31 | $1,269 |
By year: 2022 $3,572 for 40 services; 2023 $2,367 for 28 services; 2024 $2,708 for 40 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ada Hamosh prescribed most often to Medicare patients was Sapropterin Dihydrochloride, with 34 prescriptions and refills. In total Ada Hamosh wrote 158 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sapropterin Dihydrochloride Generic | 34 | 34 | Under 11 | $164K |
| Betaine Anhydrous Betaine | 34 | 34 | Under 11 | $101K |
| Ravicti Glycerol Phenylbutyrate | 23 | 23 | Under 11 | $2.3M |
| Pheburane Sodium Phenylbutyrate | 15 | 15 | Under 11 | $488K |
| Gabapentin Generic | 11 | 11 | Under 11 | $68.9 |
Brand drugs: - claims; generic drugs: 109 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ada Hamosh were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.